JP2009532415A5 - - Google Patents

Download PDF

Info

Publication number
JP2009532415A5
JP2009532415A5 JP2009503534A JP2009503534A JP2009532415A5 JP 2009532415 A5 JP2009532415 A5 JP 2009532415A5 JP 2009503534 A JP2009503534 A JP 2009503534A JP 2009503534 A JP2009503534 A JP 2009503534A JP 2009532415 A5 JP2009532415 A5 JP 2009532415A5
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
aryl
hydrogen
heterocycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009503534A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009532415A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/052914 external-priority patent/WO2007115931A1/de
Publication of JP2009532415A publication Critical patent/JP2009532415A/ja
Publication of JP2009532415A5 publication Critical patent/JP2009532415A5/ja
Pending legal-status Critical Current

Links

JP2009503534A 2006-04-06 2007-03-27 Pi3−キナーゼインヒビターとして使うためのチアゾリルジヒドロシクロペンタピラゾール Pending JP2009532415A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06112298 2006-04-06
PCT/EP2007/052914 WO2007115931A1 (de) 2006-04-06 2007-03-27 Thiazolyl-dihydro-cyclopentapyrazole zur verwendung als pi3-kinase-inhibit0ren

Publications (2)

Publication Number Publication Date
JP2009532415A JP2009532415A (ja) 2009-09-10
JP2009532415A5 true JP2009532415A5 (cg-RX-API-DMAC7.html) 2010-05-13

Family

ID=36764026

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009503534A Pending JP2009532415A (ja) 2006-04-06 2007-03-27 Pi3−キナーゼインヒビターとして使うためのチアゾリルジヒドロシクロペンタピラゾール

Country Status (15)

Country Link
US (1) US7517995B2 (cg-RX-API-DMAC7.html)
EP (1) EP2007382A1 (cg-RX-API-DMAC7.html)
JP (1) JP2009532415A (cg-RX-API-DMAC7.html)
KR (1) KR20080111118A (cg-RX-API-DMAC7.html)
CN (1) CN101460167A (cg-RX-API-DMAC7.html)
AR (1) AR060267A1 (cg-RX-API-DMAC7.html)
AU (1) AU2007236045A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0710306A2 (cg-RX-API-DMAC7.html)
CA (1) CA2647292A1 (cg-RX-API-DMAC7.html)
IL (1) IL194494A0 (cg-RX-API-DMAC7.html)
MX (1) MX2008012534A (cg-RX-API-DMAC7.html)
RU (1) RU2008143547A (cg-RX-API-DMAC7.html)
TW (1) TW200806679A (cg-RX-API-DMAC7.html)
WO (1) WO2007115931A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200807713B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004016179A1 (de) * 2004-03-30 2005-10-20 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von proliferativen Prozessen
US7691868B2 (en) 2006-04-06 2010-04-06 Boehringer Ingelheim International Gmbh Thiazolyl-dihydro-quinazoline
US20070259855A1 (en) * 2006-04-06 2007-11-08 Udo Maier Thiazolyl-dihydro-indazole
US20070238746A1 (en) * 2006-04-06 2007-10-11 Trixi Brandl Thiazolyl-dihydro-chinazoline
US20110230472A1 (en) * 2008-08-29 2011-09-22 Shionogi & Co., Ltd. Ring-fused azole derivative having pi3k-inhibiting activity
CA2738868C (en) 2008-10-01 2017-01-17 Novartis Ag Smoothened antagonism for the treatment of hedgehog pathway-related disorders
JP5579724B2 (ja) * 2008-10-17 2014-08-27 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ホスファチジルイノシトール−3−キナーゼ(pi−3キナーゼ)阻害剤としてのテトラ−アザ−複素環
WO2010125799A1 (ja) 2009-04-27 2010-11-04 塩野義製薬株式会社 Pi3k阻害活性を有するウレア誘導体
EA201200087A1 (ru) 2009-07-02 2012-07-30 Новартис Аг 2-карбоксамиды циклоаминомочевин, которые являются ингибиторами pi3k
US20140213630A1 (en) * 2011-03-08 2014-07-31 Thomas Diacovo Methods and pharmaceutical compositions for treating lymphoid malignancy
JP2014114212A (ja) * 2011-03-29 2014-06-26 Dainippon Sumitomo Pharma Co Ltd 新規ベンズイミダゾール誘導体
EA027855B1 (ru) * 2012-04-17 2017-09-29 Гайлид Сайэнсиз, Инк. Соединения и способы для противовирусной терапии
JP2022515256A (ja) 2018-12-25 2022-02-17 ソル - ゲル テクノロジーズ リミテッド Egfr阻害剤を含む組成物による皮膚障害の治療

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL357099A1 (en) 2000-02-07 2004-07-12 Abbott Gmbh & Co.Kg 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
US6608053B2 (en) * 2000-04-27 2003-08-19 Yamanouchi Pharmaceutical Co., Ltd. Fused heteroaryl derivatives
AR038703A1 (es) 2002-02-28 2005-01-26 Novartis Ag Derivados de 5-feniltiazol y uso como inhibidor de quinasa p i 3
MXPA05000453A (es) 2002-07-10 2005-03-23 Applied Research Systems Derivados de benceno fusionados a azolidinona-vinilo.
WO2004029055A1 (en) 2002-09-30 2004-04-08 Bayer Pharmaceuticals Corporation Fused azole-pyrimidine derivatives
CA2504335A1 (en) 2002-10-30 2004-05-13 Toppan Printing Co., Ltd. Apparatus of wiring pattern, inspection method, detection apparatus, detection method
BR0316386A (pt) 2002-12-06 2005-09-27 Warner Lambert Co Benzoxazin-3-onas e seus derivados como inibidores de p13k
WO2004056820A1 (en) 2002-12-20 2004-07-08 Warner-Lambert Company Llc Benzoxazines and derivatives thereof as inhibitors of pi3ks
CA2528938A1 (en) 2003-06-13 2005-02-24 Zentaris Gmbh Compounds having inhibitive activity of phosphatidylinositol 3-kinase and methods of use thereof
GB0315966D0 (en) 2003-07-08 2003-08-13 Cyclacel Ltd Compounds
DE10344223A1 (de) 2003-09-24 2005-04-21 Merck Patent Gmbh 1,3-Benzoxazolylderivate als Kinase-Inhibitoren
US7691888B2 (en) 2004-10-07 2010-04-06 Boehringer Ingelheim International Gmbh Thiazolyl-dihydro-indazole
UY29149A1 (es) 2004-10-07 2006-05-31 Boehringer Ingelheim Int Tiazolil-dihidro-indazoles

Similar Documents

Publication Publication Date Title
EP2560966B1 (en) Multisubstituted aromatic compounds as inhibitors of thrombin
CN101611013B (zh) 作为5-ht2a血清素受体调节剂用于治疗与其相关病症的吡唑衍生物
JP7595413B2 (ja) 15-pgdh阻害剤とコルチコステロイドおよび/またはtnf阻害剤との組み合わせならびにその使用
JP4667463B2 (ja) チロシンキナーゼ阻害剤として適する環状ジアリールウレア
JP2014516074A5 (cg-RX-API-DMAC7.html)
EP2170865A2 (fr) Indazoles substitues, leur preparation et leur utilisation en therapeutique
JP2009526037A (ja) トリアゾロピリジン化合物
JP6618525B2 (ja) ピラゾール類
JP2020523388A5 (cg-RX-API-DMAC7.html)
CA2642211A1 (en) 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
JP2007524696A5 (cg-RX-API-DMAC7.html)
JP2010502717A (ja) インターロイキン1受容体関連キナーゼの調節物質
JP2007519694A5 (cg-RX-API-DMAC7.html)
WO1999062885A1 (en) Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents
CA2901332A1 (en) Trk-inhibiting compound
RU2008143547A (ru) Тиазолилдигидроциклопентапиразолы для применения в качестве ингибиторов pi3-киназы
CA2709786A1 (en) 4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof
AU1039300A (en) 4,5-dihydro-isoxazole derivatives and their pharmaceutical use
RU2008112691A (ru) Азотсодержащее гетероциклическое соединение и его фармацевтическое применение
KR20090005296A (ko) 뒤시엔느 근이영양증의 치료
MA32642B1 (fr) Amides utiles en therapie
AU2018356430A1 (en) Aromatic sulfonamide derivatives for the treatment of Ischemic Stroke
JP2011513295A (ja) インダゾール誘導体
JP2016527184A5 (cg-RX-API-DMAC7.html)
CN110325515A (zh) 作为ⅲ型受体酪氨酸激酶抑制剂的喹喔啉化合物